IN2012DN00909A - - Google Patents

Info

Publication number
IN2012DN00909A
IN2012DN00909A IN909DEN2012A IN2012DN00909A IN 2012DN00909 A IN2012DN00909 A IN 2012DN00909A IN 909DEN2012 A IN909DEN2012 A IN 909DEN2012A IN 2012DN00909 A IN2012DN00909 A IN 2012DN00909A
Authority
IN
India
Prior art keywords
micro
drug
carrier
released
finally
Prior art date
Application number
Inventor
C Yu Chris
He Yu
Original Assignee
Anpac Bio Medical Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anpac Bio Medical Science Co Ltd filed Critical Anpac Bio Medical Science Co Ltd
Publication of IN2012DN00909A publication Critical patent/IN2012DN00909A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097—Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Abstract

A drug delivery method is disclosed. A micro-carrier delivers an encapsulated drug directly to targeted sites without significant interactions with other components in the biological system. In one embodiment, a micro-carrier is first delivered to the general area for treatment. It then scans the area and selectively attaches itself to the cell site or organ location to be treated. Finally, the desired drug contained in the micro-earner is released to the attached site. In another embodiment, a micro-device is first used to process the general area to enhance differentiation in properties between cells and unhealthy cells. Drug is encapsulated in the micro-carrier to preferentially attach onto the targeted sites. Finally, drug is released from the micro-carrier onto the sites. Such microcarriers preferably contains multiple functions comprised of at least two of sensing, analyzing, logic processing, surface treatment, position detection, motion, injecting, delivering, cutting functions, removing functions, biodegradation and disintegration.
IN909DEN2012 2009-07-07 2010-07-03 IN2012DN00909A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/498,698 US10105317B2 (en) 2009-07-07 2009-07-07 Method of drug delivery
PCT/US2010/041001 WO2011005720A1 (en) 2009-07-07 2010-07-03 Method of drug delivery

Publications (1)

Publication Number Publication Date
IN2012DN00909A true IN2012DN00909A (en) 2015-04-03

Family

ID=43427656

Family Applications (1)

Application Number Title Priority Date Filing Date
IN909DEN2012 IN2012DN00909A (en) 2009-07-07 2010-07-03

Country Status (13)

Country Link
US (1) US10105317B2 (en)
EP (1) EP2451443B1 (en)
JP (2) JP5950405B2 (en)
KR (1) KR20120059495A (en)
CN (1) CN102481259A (en)
AU (1) AU2010270766B2 (en)
BR (1) BR112012000420B8 (en)
CA (2) CA2766766C (en)
IL (1) IL217072A (en)
IN (1) IN2012DN00909A (en)
NZ (1) NZ597164A (en)
WO (1) WO2011005720A1 (en)
ZA (1) ZA201109514B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10624847B2 (en) * 2011-08-02 2020-04-21 AnPac BioMedical Science Co., Ltd. Decomposable apparatus and methods for fabricating same
TWI711819B (en) 2012-07-16 2020-12-01 大陸商昌和生物醫學科技（揚州）有限公司 Devices and methods for enhanced detection and identification of diseases
CN107051597B (en) * 2013-01-07 2019-08-09 安派科生物医学科技（丽水）有限公司 The disease detection instrument of improvement
CN105705088A (en) 2013-03-15 2016-06-22 安派科生物医学科技（丽水）有限公司 Methods and apparatus for enhanced detection of diseases
CN105695327B (en) 2016-04-06 2018-09-07 京东方科技集团股份有限公司 A kind of nanometer robot
WO2018056584A1 (en) 2016-09-21 2018-03-29 삼성전자 주식회사 Method for measuring skin condition and electronic device therefor
CN106448794B (en) * 2016-10-14 2018-08-07 武汉理工大学 Semiconductor microactuator nano-particle directed movement control method

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218685T3 (en) 1997-06-13 2004-11-16 Nanodel Technologies Gmbh SYSTEM FOR PHARMACO ADDRESS, PROCEDURE FOR PREPARATION AND USE.
US6165440A (en) 1997-07-09 2000-12-26 Board Of Regents, The University Of Texas System Radiation and nanoparticles for enhancement of drug delivery in solid tumors
US20030007991A1 (en) 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US6773823B2 (en) 2000-04-07 2004-08-10 University Of New Orleans Research And Technology Foundation, Inc. Sequential synthesis of core-shell nanoparticles using reverse micelles
US6663615B1 (en) * 2001-09-04 2003-12-16 The Ohio State University Dual stage microvalve and method of use
ATE424795T1 (en) 2002-06-05 2009-03-15 Univ Florida OPHTHALMIC DRUG DELIVERY SYSTEM
JP2004231575A (en) * 2003-01-30 2004-08-19 Terumo Corp Composition for delivering medicament to specific target site
WO2004101023A2 (en) * 2003-05-06 2004-11-25 Becton Dickinson And Company A method for altering insulin pharmacokinetics
US20040236278A1 (en) 2003-05-22 2004-11-25 Atrium Medical Corp. Therapeutic agent delivery
CA2549341C (en) 2003-12-19 2014-06-10 The University Of North Carolina At Chapel Hill Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
US7182894B2 (en) 2004-03-12 2007-02-27 Council Of Scientific & Industrial Research Process for the preparation of free standing membranes
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US7527668B2 (en) 2004-07-08 2009-05-05 Mitsubishi Materials Corporation Method for manufacturing metal fine particles, metal fine particles manufactured thereby, and composition, light absorbing material and applied products containing the same
US20060040390A1 (en) 2004-08-19 2006-02-23 Minor John S Jr Device, method, system, and program for intelligent in vivo cell-level chemical or genetic material delivery
EP1841490A2 (en) * 2005-01-18 2007-10-10 Koninklijke Philips Electronics N.V. Electronically controlled capsule
US20060283465A1 (en) 2005-06-16 2006-12-21 Nickel Janice H Smart drug delivery system and a method of implementation thereof
EP2460868A3 (en) 2006-01-06 2013-06-19 National University of Singapore Method of preparing nano-structured material(s) and uses thereof
US20080269948A1 (en) 2006-11-13 2008-10-30 Solomon Research Llc Hybrid control system for collectives of evolvable nanorobots and microrobots
WO2008112565A2 (en) 2007-03-09 2008-09-18 Anthony Manganaro Method and composition for treating cancer
WO2009018467A2 (en) 2007-07-31 2009-02-05 Massachusetts Institute Of Technology Bio-sensing nanodevice

Also Published As

Publication number Publication date
JP5950405B2 (en) 2016-07-13
CA2766766A1 (en) 2011-01-13
EP2451443B1 (en) 2017-05-03
EP2451443A1 (en) 2012-05-16
BR112012000420B1 (en) 2020-09-29
JP2016193919A (en) 2016-11-17
ZA201109514B (en) 2012-09-26
JP6174757B2 (en) 2017-08-02
US20110008446A1 (en) 2011-01-13
KR20120059495A (en) 2012-06-08
CA3073148A1 (en) 2011-01-13
IL217072A (en) 2017-06-29
BR112012000420B8 (en) 2021-07-27
CA2766766C (en) 2020-04-07
AU2010270766B2 (en) 2016-09-15
BR112012000420A2 (en) 2016-04-12
JP2012532675A (en) 2012-12-20
EP2451443A4 (en) 2014-03-12
IL217072A0 (en) 2012-02-29
CN102481259A (en) 2012-05-30
NZ597164A (en) 2014-07-25
AU2010270766A1 (en) 2012-01-19
WO2011005720A1 (en) 2011-01-13
US10105317B2 (en) 2018-10-23

Similar Documents

Publication Publication Date Title
IN2012DN00909A (en)
WO2010141377A3 (en) Method and system for directing a localized biological response to an implant
MX2013000201A (en) Methods of delivering a health care active by administering personal health care articles comprising a filament.
WO2014167360A3 (en) Method for treating a substrate made of animal fibers with solid particles and a chemical formulation
GB201019434D0 (en) Sonosensitive nanoparticles
WO2012019168A3 (en) Engineered nucleic acids and methods of use thereof
NZ710443A (en) Method of identifying disease risk factors
BRPI0716470A2 (en) ULTRASONIC LIQUID TREATMENT AND DISTRIBUTION SYSTEM AND PROCESS
WO2006113267A3 (en) A fluid delivery system
NZ703820A (en) Permeant delivery system and methods for use thereof
MX364396B (en) Modified poly(beta-amino ester)s for drug delivery.
WO2008058683A3 (en) Arrangement and method for the analysis of biological samples
WO2010091376A3 (en) Devices and methods for perfusion therapy
WO2011039736A3 (en) Device and method for drug delivery to a targeted skin layer
WO2013136189A3 (en) Methods and materials for treatment of pompe's disease
PT3095458T (en) Pharmaceutical composition for treating cancer comprising trypsinogen and chymotrypsinogen
BRPI0916174A2 (en) "display system, method and product of computer program"
WO2007133750A3 (en) Encapsulated nanoparticles for drug delivery
NZ597269A (en) Aptamer for chymase, and use thereof
WO2011015701A3 (en) Lipid nanoparticles for gene therapy
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
UA105940C2 (en) Drug formulation with theobromine and opiate for treatment of cough
WO2012162546A3 (en) Lance device and associated methods for delivering a biological material into a cell
EP2578232A4 (en) Treatment drug for autoimmune diseases and allergic diseases
UA95489C2 (en) Method for determination of cytotoxic/cytoprotector effect of destabilizing factors